TransEnterix to Present at the Stifel 2017 Healthcare Conference

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the Stifel 2017 Healthcare Conference at The Lotte New York Palace Hotel in New York, New York. The presentation is scheduled to take place at 5:00 PM Eastern Time on Tuesday, November 14, 2017.

About TransEnterix

TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options. The Company is focused on the commercialization of the Senhance™ Surgical Robotic System, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye sensing camera control. The Company also developed the SurgiBot™ System, a single-port, robotically enhanced laparoscopic surgical platform. The Senhance Surgical Robotic System is available for sale in the US, the EU and select other countries. For more information, visit the TransEnterix website at www.transenterix.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171031005270/en/

For TransEnterix, Inc.
Investors:
Mark Klausner, +1-443-213-0501
[email protected]
or
Media:
Joanna Rice, +1-951-751-1858
[email protected]

Source: TransEnterix, Inc.

You May Also Be Interested In

• Danaher (DHR) PT Raised to $260 at Stifel as Nonrespiratory Core Growth Exceeded Expectations
• Eylsia Nicolas Hits #1 in the United States as Her Multi‑Category Chart Sweep Extends Across Global All‑Genres and International Markets
• Seniors Implement Consulting Introduces Enterprise Value Intelligence for Better Business Decisions